Despite the improvement in understanding its pathogenesis and the introduction of novel
treatment options, the management of primary immune thrombocytopenia (ITP) still remains …

Splenectomy increases lifetime risk of thromboembolism (VTE) and is associated with long-
term infectious complications, primarily, overwhelming post-splenectomy infection (OPSI) …

Background Splenectomy is performed frequently for various and primarily hematologic
indications in children and adolescents. We analyzed the long-term outcome after …

Lower extremity deep vein thrombosis (DVT) is a common peripheral vascular disease, in
which inflammation plays an important role. The aim of the present study was to investigate …

Splenectomy is considered therapeutic in various non‐malignant haematologic diseases.
Adverse events‒specifically infections and thromboembolism‒are not extensively …

Results The mean age of the patients who underwent splenectomy was 6.68±2.54 years
and the mean postoperative follow-up period was 6.26±3.03 years. Splenectomy improves …

Background Few studies have investigated long‐term survival in patients with primary
immune thrombocytopenia (pITP). Further, changes in prognosis over the past decades and …

Introduction Immune thrombocytopenia (ITP) is an autoimmune disease characterized by
low platelet counts and increased risk of bleeding. After corticosteroids with or without …

Splenectomy is a common surgical procedure performed in millions of people worldwide.
Epidemiologic data show that splenectomy is followed by infectious (sepsis) and non …

Immune thrombocytopenic purpura (ITP) is an acquired immune-mediated disease
characterized by a decrease in platelet count due to antiplatelet autoantibody-mediated …